MedTrace Logo

Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound

NCT04756193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2024-10-30

No results posted yet for this study

Summary

We hypothesize that recovered COVID-19 patients suffer long term cardiovascular and pulmonary complications, which can be detected by point of care ultrasound. The goal is to comprehensively delineate the long term cardiovascular and pulmonary ultrasound findings in recovered COVID-19 patients, identify risks factors for prolonged heart/lung injury, evaluate long term effects of applied treatment, and assess late medication/vaccine side effects in COVID-19 patients.

Conditions

  • Covid19
  • Echocardiography
  • Ultrasound

Interventions

DIAGNOSTIC_TEST

Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound

Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound, ECG, pulse oximetry, blood draw, spirometry

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • University of Louisville

    lead OTHER

Principal Investigators

  • Jiapeng Huang, MD, PhD · University of Louisville

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2024-09-24
Completion
2024-09-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756193 on ClinicalTrials.gov